Together, the exciting findings gathered in the last decade clearly indicate a crucial multifaceted role for chemerin in the regulation of energy balance, making it a promising candidate for urgently needed pharmacological treatment strategies for obesity. Here, RARRES2 is linked to obesity due to melanocortin 4 receptor deficiency.